Notice NOT-DA-17-032 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-031 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-033 from the NIH Guide for Grants and Contracts

Notice NOT-AG-17-007 from the NIH Guide for Grants and Contracts

Notice NOT-DA-17-030 from the NIH Guide for Grants and Contracts

Notice NOT-TR-17-016 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AR-18-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing interventional clinical trials. The ongoing parent project has to be an interventional clinical trial that can provide a cohort of well-characterized patients, infrastructure, data, and biological samples. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Funding Opportunity RFA-AR-18-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing interventional clinical trials. The ongoing parent project has to be an interventional clinical trial that can provide a cohort of well-characterized patients, infrastructure, data, and biological samples. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Notice NOT-HL-17-511 from the NIH Guide for Grants and Contracts

Ideal candidate will be a software engineer or computational biologist that can think from the point of view of a biologist while understanding computer science...
From Indeed - Mon, 01 May 2017 15:18:04 GMT - View all Cambridge jobs

Funding Opportunity RFA-MH-18-300 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. RFA-MH-18-300 uses the R01 grant mechanism while RFA-MH-18-301 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data may wish to apply using the R01 mechanism.

Funding Opportunity RFA-MH-18-301 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence in myeloid cells and strategies to target this reservoir in the central nervous system. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. RFA-MH-18-300 uses the R01 grant mechanism while RFA-MH-18-301 uses the R21 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism, while applicants with preliminary data may wish to apply using the R01 mechanism.

Funding Opportunity RFA-HD-18-010 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications from institutions/organizations willing to participate with the NICHD as the Data Coordinating Center (DCC) under a cooperative agreement in an ongoing multi-center research network designed to perform observational and interventional clinical studies, using common protocols, to improve outcomes for neonates.

Notice NOT-RM-17-028 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-027 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-026 from the NIH Guide for Grants and Contracts

Requires a Ph.D in bioinformatics, statistics, mathematics, computer science and 3 years of directly related experience;...
From Sanford Burnham Prebys Medical Discovery Institute - Sun, 30 Apr 2017 05:36:43 GMT - View all La Jolla jobs

Proven knowledge and expertise in statistics and its application to analyze laboratory data, data mining and/or bioinformatics and their applications to... $65 - $75 an hour
From Indeed - Sat, 29 Apr 2017 18:12:15 GMT - View all Cambridge jobs

PhD in biology-related field with significant software computational data analysis experience and product or project management-related experience....
From QIAGEN - Sat, 29 Apr 2017 00:59:07 GMT - View all Germantown jobs

Be the point of contact for computational support of drug discovery program teams that are utilizing team-derived automation platforms....
From Indeed - Sat, 29 Apr 2017 00:28:30 GMT - View all Collegeville jobs